Next Article in Journal
The ClC-2 Chloride Channel Activator, Lubiprostone, Improves Intestinal Barrier Function in Biopsies from Crohn’s Disease but Not Ulcerative Colitis Patients
Next Article in Special Issue
Highlighted Advances in Therapies for Difficult-To-Treat Brain Tumours Such as Glioblastoma
Previous Article in Journal
Hybrid Materials with Antimicrobial Properties Based on Hyperbranched Polyaminopropylalkoxysiloxanes Embedded with Ag Nanoparticles
Previous Article in Special Issue
In Silico Studies to Support Vaccine Development
 
 
Article

Article Versions Notes

Pharmaceutics 2023, 15(3), 810; https://doi.org/10.3390/pharmaceutics15030810
Action Date Notes Link
article xml file uploaded 2 March 2023 06:52 CET Original file -
article xml uploaded. 2 March 2023 06:52 CET Update https://www.mdpi.com/1999-4923/15/3/810/xml
article pdf uploaded. 2 March 2023 06:52 CET Version of Record https://www.mdpi.com/1999-4923/15/3/810/pdf
article supplementary file uploaded. 2 March 2023 06:52 CET - https://www.mdpi.com/1999-4923/15/3/810#supplementary
article html file updated 2 March 2023 06:53 CET Original file -
article html file updated 20 March 2023 20:08 CET Update https://www.mdpi.com/1999-4923/15/3/810/html
Back to TopTop